Executives from nine of Australia’s top biotechnology firms will present “what’s hot” in biotech Down Under on Thursday, May 3, at the second annual Australian Bio-Investment Forum in New York City. Hosted by Australian investment and brokerage firm Emerging Growth Capital (eG Capital), the conference is being held at the offices of Ernst & Young, Five Times Square.
